Filter
2237
Filtered Results: 2237
Text search:
drug-resistant
TB
Featured
Recommendations
225
New Publications
615
Language
Document type
No document type
1428
Studies & Reports
281
Guidelines
255
Manuals
79
Strategic & Response Plan
69
Situation Updates
43
Fact sheets
35
Training Material
30
Infographics
9
Brochures
4
Online Courses
3
Videos
1
Countries / Regions
India
127
South Africa
73
Kenya
72
Western and Central Europe
71
Global
52
Eastern Europe
50
Nepal
49
Tanzania
48
Ethiopia
46
Uganda
40
Zambia
39
Namibia
37
Nigeria
36
Malawi
32
Myanmar / Burma
31
Ghana
30
Sierra Leone
30
Liberia
30
Africa
28
Latin America and the Carribbean
28
Bangladesh
27
Rwanda
25
Lesotho
24
Cambodia
23
Asia
23
Ukraine
20
Philippines
18
South–East Asia Region
16
Zimbabwe
15
Indonesia
15
Russia
14
Botswana
14
Colombia
12
Senegal
12
Mozambique
11
Eswatini/ Swaziland
9
Pakistan
9
Tajikistan
8
Germany
8
Argentina
8
Cameroon
7
Albania
7
Haiti
7
Venezuela
7
Congo, Democratic Republic of
7
Burkina Faso
6
Thailand
5
El Salvador
5
Peru
5
Armenia
5
West and Central Africa
5
East and Southern Africa
5
Brazil
5
Georgia
5
Syria
4
Laos
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Paraguay
4
Vietnam
4
Sudan
4
South Sudan
4
North Macedonia
3
Timor Leste/ East Timor
3
Benin
3
Estonia
3
Guinea
3
Western Pacific Region
3
Uruguay
3
Bolivia
3
Moldova
3
Sri Lanka
3
Switzerland
2
Iran
2
Afghanistan
2
Morocco
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Nicaragua
2
Romania
2
Honduras
2
Bhutan
2
Ecuador
2
Madagascar
2
Guatemala
2
North Korea
1
Mexico
1
Gambia
1
China
1
Chile
1
Bulgaria
1
USA
1
Dominican Republic
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
North America
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Yemen
1
Greece
1
Central African Republic
1
Poland
1
Angola
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
921
Clinical Guidelines
190
Public Health
69
Women & Child Health
40
Key Resources
40
Capacity Building
31
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
TB
671
HIV
292
AMR
181
Pharmacy
47
NTDs
45
COVID-19
35
Caregiver
29
Ebola & Marburg
28
Global Health Education
25
Refugee
24
Mental Health
20
Health Financing Toolbox
19
Polio
19
Conflict
18
Planetary Health
15
Malaria
15
Rapid Response
14
NCDs
14
2.0 Rapid Response
7
Disability
6
Natural Hazards
5
Cholera
3
Specific Hazards
2
Social Ethics
2
Zika
1
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
From policy to practice: how the TB-HIV response is working
“The HIV community must place much more focus on TB co-infection than
it has done to date. TB takes the lives of over 1000 people living with HIV
every day, a number which is absolutely unacceptable. This report highlights that
TB d...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma...
Revista Peruana de Medicina Experimental y Salud Pública 2017 Vol 34 (2)
En el presente artículo se desarrolla la situación epidemiológica de la TB en el Perú al 2015, los avances en su control, de acuerdo a tres enfoques: biomédico, de gestión pública y de determinantes sociales de la salu...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant...
The Creditor Reporting System was analysed for official development assistance funding disbursements towards TB control in 11 conflict-affectedstates, 17 non-conflict-affected fragile states and 38 comparable non-fragile states. The amounts of funding, funding relative to burden, funding relative to...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs through the Global Action Plan for Healthy Lives and Well-being for All. Understanding patterns of inequal...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The Region of the Americas comprises 46 countries and territories and Brazil and Peru are among the WHO high- TB burden
countries. T o illustrate the recent increase in TB incidence in the region, we selected 12 countries from Latin America (Argentina,
Brazil, Chile, Colombia, Ecuador, El Salvador...
UN GUIDE POUR L’APPROVISIONNEMENTEN MÉDICAMENTS/ A guide for drug supply
Bochure in English and French
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to...
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
